DENTSPLY SIRONA (XRAY) Stock Forecast, Price Target & Predictions
XRAY Stock Forecast
DENTSPLY SIRONA stock forecast is as follows: an average price target of $29.50 (represents a 57.75% upside from XRAY’s last price of $18.70) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
XRAY Price Target
The average price target for DENTSPLY SIRONA (XRAY) is $29.50 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $31.00 to $28.00. This represents a potential 57.75% upside from XRAY's last price of $18.70.
XRAY Analyst Ratings
According to 5 Wall Street analysts, DENTSPLY SIRONA's rating consensus is 'Hold'. The analyst rating breakdown for XRAY stock is 0 'Strong Buy' (0.00%), 2 'Buy' (40.00%), 3 'Hold' (60.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
DENTSPLY SIRONA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 22, 2024 | Jeff Johnson | Robert W. Baird | $31.00 | $26.36 | 17.60% | 65.78% |
| Jul 18, 2024 | Jonathan Block | Stifel Nicolaus | $28.00 | $27.54 | 1.67% | 49.73% |
| May 03, 2024 | Jason Bednar | Piper Sandler | $32.00 | $28.13 | 13.76% | 71.12% |
| Nov 16, 2023 | David Saxon | Needham | $35.00 | $29.61 | 18.18% | 87.17% |
| Jun 01, 2022 | Kevin Caliendo | UBS | $47.00 | $39.04 | 20.39% | 151.34% |
| Apr 22, 2022 | H.C. Wainwright | $48.00 | $42.09 | 14.04% | 156.68% | |
| Apr 21, 2022 | Goldman Sachs | $47.00 | $42.89 | 9.58% | 151.34% | |
| Apr 20, 2022 | Morgan Stanley | $52.00 | $42.89 | 21.24% | 178.07% | |
| Apr 20, 2022 | Piper Sandler | $46.00 | $42.20 | 9.00% | 145.99% | |
| Apr 19, 2022 | Jeffrey Johnson | Robert W. Baird | $48.00 | $42.63 | 12.60% | 156.68% |
| Nov 04, 2021 | Jonathan Block | Stifel Nicolaus | $60.00 | $54.69 | 9.71% | 220.86% |
| Aug 06, 2021 | Jason Bednar | Piper Sandler | $75.00 | $59.91 | 25.19% | 301.07% |
The latest DENTSPLY SIRONA stock forecast, released on Jul 22, 2024 by Jeff Johnson from Robert W. Baird, set a price target of $31.00, which represents a 17.60% increase from the stock price at the time of the forecast ($26.36), and a 65.78% increase from XRAY last price ($18.70).
DENTSPLY SIRONA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 3 |
| Avg Price Target | - | - | $30.33 |
| Last Closing Price | $18.70 | $18.70 | $18.70 |
| Upside/Downside | -100.00% | -100.00% | 62.19% |
In the current month, the average price target of DENTSPLY SIRONA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to DENTSPLY SIRONA's last price of $18.70. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 08, 2024 | Evercore ISI | Underperform | Underperform | Hold |
| Sep 27, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Sep 20, 2024 | Needham | Buy | Buy | Hold |
| Aug 20, 2024 | Needham | Buy | Buy | Hold |
| Aug 20, 2024 | Evercore Partners | Underperform | Underperform | Hold |
| Jul 18, 2024 | Piper Sandler | Buy | Buy | Hold |
| Jul 18, 2024 | Needham | Underperform | Underperform | Hold |
| Jun 25, 2024 | Piper Sandler | Buy | Buy | Hold |
| May 06, 2024 | Piper Sandler | Buy | Buy | Hold |
| May 03, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Apr 18, 2024 | Needham | Buy | Buy | Hold |
| Apr 18, 2024 | Leerink Partners | Underperform | Underperform | Hold |
| Feb 29, 2024 | Piper Sandler | Buy | Buy | Hold |
| Feb 29, 2024 | Needham | Underperform | Underperform | Hold |
| Nov 16, 2023 | Needham | Buy | Initialise | |
| Aug 03, 2023 | William Blair | Market Perform | Market Perform | Hold |
| Feb 28, 2023 | William Blair | Market Perform | Market Perform | Hold |
| Jan 11, 2023 | William Blair | Market Perform | Upgrade | |
| Jan 11, 2023 | Piper Sandler | Neutral | Neutral | Hold |
| Jun 01, 2022 | UBS | Buy | Upgrade | |
| May 12, 2022 | Deutsche Bank | Hold | Hold | Hold |
DENTSPLY SIRONA's last stock rating was published by Evercore ISI on Oct 08, 2024. The company gave XRAY a "Underperform" rating, the same as its previous rate.
DENTSPLY SIRONA Financial Forecast
DENTSPLY SIRONA Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $947.00M | $1.03B | $978.00M | $983.00M | $947.00M | $1.02B | $965.00M | $1.09B | $1.07B | $1.07B | $1.03B | $1.08B | $894.80M |
| Avg Forecast | $978.32M | $976.19M | $974.06M | $971.94M | $986.02M | $950.71M | $993.22M | $942.41M | $946.65M | $922.47M | $962.05M | $916.18M | $922.82M | $939.10M | $993.61M | $969.45M | $971.51M | $975.21M | $998.98M | $937.70M | $941.92M | $1.01B | $1.01B | $991.01M | $1.13B | $1.03B | $1.01B | $947.57M | $997.38M | $839.02M |
| High Forecast | $999.47M | $997.29M | $995.12M | $992.96M | $1.01B | $971.26M | $1.01B | $962.78M | $967.11M | $942.41M | $982.85M | $949.33M | $993.67M | $939.87M | $993.61M | $969.45M | $994.25M | $975.31M | $1.02B | $957.97M | $962.28M | $1.01B | $1.01B | $991.01M | $1.13B | $1.03B | $1.01B | $947.57M | $997.38M | $839.02M |
| Low Forecast | $961.58M | $959.49M | $957.40M | $955.31M | $969.15M | $934.44M | $976.23M | $926.28M | $930.45M | $906.69M | $945.59M | $897.26M | $900.85M | $938.32M | $993.61M | $969.45M | $951.41M | $975.12M | $981.88M | $921.66M | $925.80M | $1.01B | $1.01B | $991.01M | $1.13B | $1.03B | $1.01B | $947.57M | $997.38M | $839.02M |
| # Analysts | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 1.03% | 1.04% | 1.04% | 0.94% | 1.01% | 0.97% | 0.96% | 1.04% | 1.05% | 1.08% | 1.09% | 1.07% |
DENTSPLY SIRONA's average Quarter revenue forecast for Dec 23 based on 10 analysts is $971.51M, with a low forecast of $951.41M, and a high forecast of $994.25M. XRAY's average Quarter revenue forecast represents a 2.59% increase compared to the company's last Quarter revenue of $947.00M (Sep 23).
DENTSPLY SIRONA EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $77.00M | $158.00M | $138.00M | $34.00M | $142.00M | $197.00M | $182.00M | $235.00M | $239.00M | $243.00M | $254.00M | $226.90M | $188.00M |
| Avg Forecast | $76.40M | $76.23M | $76.07M | $75.90M | $77.00M | $74.24M | $77.56M | $73.59M | $73.92M | $72.04M | $75.13M | $71.55M | $72.06M | $73.34M | $77.59M | $207.93M | $75.87M | $76.16M | $78.01M | $189.02M | $268.32M | $202.46M | $203.27M | $171.84M | $226.80M | $205.94M | $203.37M | $179.29M | $200.35M | $168.54M |
| High Forecast | $78.05M | $77.88M | $77.71M | $77.54M | $78.66M | $75.85M | $79.24M | $75.18M | $75.52M | $73.59M | $76.75M | $74.13M | $77.60M | $73.40M | $77.59M | $249.51M | $77.64M | $76.16M | $79.70M | $226.83M | $321.98M | $202.46M | $203.27M | $206.21M | $226.80M | $205.94M | $203.37M | $215.14M | $200.35M | $168.54M |
| Low Forecast | $75.09M | $74.93M | $74.76M | $74.60M | $75.68M | $72.97M | $76.24M | $72.33M | $72.66M | $70.80M | $73.84M | $70.07M | $70.35M | $73.27M | $77.59M | $166.34M | $74.30M | $76.15M | $76.68M | $151.22M | $214.65M | $202.46M | $203.27M | $137.47M | $226.80M | $205.94M | $203.37M | $143.43M | $200.35M | $168.54M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 2.03% | 0.73% | 0.13% | 0.70% | 0.97% | 1.06% | 1.04% | 1.16% | 1.19% | 1.42% | 1.13% | 1.12% |
10 analysts predict XRAY's average Quarter EBITDA for Dec 23 to be $75.87M, with a high of $77.64M and a low of $74.30M. This is -1.47% lower than DENTSPLY SIRONA's previous annual EBITDA (Sep 23) of $77.00M.
DENTSPLY SIRONA Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-266.00M | $86.00M | $-23.00M | $-15.00M | $-1.08B | $73.00M | $65.00M | $102.00M | $103.00M | $99.00M | $117.00M | $98.50M | $53.80M |
| Avg Forecast | $83.61M | $94.43M | $99.11M | $86.87M | $116.42M | $113.27M | $115.91M | $99.54M | $104.99M | $99.69M | $100.06M | $84.16M | $86.28M | $95.36M | $99.76M | $75.50M | $87.04M | $97.25M | $86.80M | $68.64M | $116.46M | $107.40M | $112.72M | $62.40M | $161.99M | $133.50M | $136.62M | $83.57M | $131.88M | $65.09M |
| High Forecast | $85.96M | $97.08M | $101.90M | $89.32M | $119.69M | $116.45M | $119.17M | $102.34M | $107.94M | $102.49M | $102.87M | $100.20M | $120.80M | $95.62M | $99.79M | $90.60M | $93.11M | $97.27M | $89.24M | $82.37M | $139.75M | $107.40M | $112.72M | $74.88M | $161.99M | $133.50M | $136.62M | $100.29M | $131.88M | $65.09M |
| Low Forecast | $81.75M | $92.33M | $96.91M | $84.94M | $113.83M | $110.75M | $113.33M | $97.32M | $102.65M | $97.47M | $97.83M | $76.15M | $78.61M | $95.10M | $99.73M | $60.40M | $85.01M | $97.24M | $84.87M | $54.91M | $93.17M | $107.40M | $112.72M | $49.92M | $161.99M | $133.50M | $136.62M | $66.86M | $131.88M | $65.09M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.74% | 0.99% | -0.34% | -0.13% | -10.03% | 0.65% | 1.04% | 0.63% | 0.77% | 0.72% | 1.40% | 0.75% | 0.83% |
DENTSPLY SIRONA's average Quarter net income forecast for Sep 23 is $97.25M, with a range of $97.24M to $97.27M. XRAY's average Quarter net income forecast represents a 13.09% increase compared to the company's last Quarter net income of $86.00M (Jun 23).
DENTSPLY SIRONA SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $372.00M | $416.00M | $416.00M | $402.00M | $401.00M | $410.00M | $374.00M | $374.00M | $394.00M | $398.00M | $385.00M | $420.50M | $341.90M |
| Avg Forecast | $398.32M | $397.45M | $396.58M | $395.72M | $401.45M | $387.08M | $404.38M | $383.69M | $385.42M | $375.58M | $391.69M | $373.02M | $375.72M | $382.35M | $404.54M | $434.44M | $395.54M | $397.05M | $406.73M | $394.94M | $427.02M | $409.84M | $411.47M | $359.04M | $459.11M | $416.89M | $411.67M | $275.00M | $405.57M | $341.18M |
| High Forecast | $406.93M | $406.04M | $405.16M | $404.28M | $410.13M | $395.44M | $413.13M | $391.99M | $393.75M | $383.70M | $400.16M | $386.51M | $404.57M | $382.66M | $404.54M | $521.33M | $404.80M | $397.09M | $415.52M | $473.93M | $512.43M | $409.84M | $411.47M | $430.85M | $459.11M | $416.89M | $411.67M | $330.00M | $405.57M | $341.18M |
| Low Forecast | $391.50M | $390.65M | $389.80M | $388.95M | $394.58M | $380.45M | $397.47M | $377.13M | $378.83M | $369.15M | $384.99M | $365.31M | $366.77M | $382.03M | $404.54M | $347.55M | $387.36M | $397.01M | $399.77M | $315.96M | $341.62M | $409.84M | $411.47M | $287.23M | $459.11M | $416.89M | $411.67M | $220.00M | $405.57M | $341.18M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 1.02% | 1.05% | 0.94% | 0.98% | 1.00% | 1.04% | 0.81% | 0.95% | 0.97% | 1.40% | 1.04% | 1.00% |
DENTSPLY SIRONA's average Quarter SG&A projection for Dec 23 is $395.54M, based on 10 Wall Street analysts, with a range of $387.36M to $404.80M. The forecast indicates a 6.33% rise compared to XRAY last annual SG&A of $372.00M (Sep 23).
DENTSPLY SIRONA EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 11 | 5 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.26 | $0.41 | $-0.11 | $-0.07 | $-5.01 | $0.34 | $0.32 | $0.47 | $0.47 | $0.45 | $0.53 | $0.45 | $0.25 |
| Avg Forecast | $0.42 | $0.47 | $0.49 | $0.43 | $0.58 | $0.56 | $0.58 | $0.50 | $0.52 | $0.50 | $0.50 | $0.42 | $0.43 | $0.47 | $0.50 | $0.42 | $0.43 | $0.48 | $0.43 | $0.34 | $0.33 | $0.52 | $0.55 | $0.56 | $0.79 | $0.65 | $0.66 | $0.57 | $0.64 | $0.32 |
| High Forecast | $0.43 | $0.48 | $0.51 | $0.44 | $0.60 | $0.58 | $0.59 | $0.51 | $0.54 | $0.51 | $0.51 | $0.50 | $0.60 | $0.48 | $0.50 | $0.42 | $0.46 | $0.48 | $0.44 | $0.35 | $0.33 | $0.52 | $0.55 | $0.56 | $0.79 | $0.65 | $0.66 | $0.57 | $0.64 | $0.32 |
| Low Forecast | $0.41 | $0.46 | $0.48 | $0.42 | $0.57 | $0.55 | $0.56 | $0.48 | $0.51 | $0.48 | $0.49 | $0.38 | $0.39 | $0.47 | $0.50 | $0.42 | $0.42 | $0.48 | $0.42 | $0.33 | $0.32 | $0.52 | $0.55 | $0.56 | $0.79 | $0.65 | $0.66 | $0.57 | $0.64 | $0.32 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.60% | 0.95% | -0.32% | -0.21% | -9.59% | 0.62% | 0.57% | 0.60% | 0.72% | 0.68% | 0.93% | 0.70% | 0.79% |
According to 9 Wall Street analysts, DENTSPLY SIRONA's projected average Quarter EPS for Sep 23 is $0.48, with a low estimate of $0.48 and a high estimate of $0.48. This represents a 18.01% increase compared to XRAY previous annual EPS of $0.41 (Jun 23).
DENTSPLY SIRONA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| XRAY | DENTSPLY SIRONA | $19.19 | $29.50 | 53.73% | Hold |
| TFX | Teleflex | $178.28 | $254.50 | 42.75% | Buy |
| ANGO | AngioDynamics | $9.26 | $13.00 | 40.39% | Buy |
| HAE | Haemonetics | $82.07 | $107.00 | 30.38% | Buy |
| BDX | Becton, Dickinson and Company | $225.64 | $278.75 | 23.54% | Buy |
| COO | Cooper Companies | $94.49 | $115.00 | 21.71% | Buy |
| ALC | Alcon | $85.54 | $104.00 | 21.58% | Buy |
| ICUI | ICU Medical | $157.17 | $190.50 | 21.21% | Buy |
| WST | West Pharmaceutical Services | $334.26 | $393.00 | 17.57% | Buy |
| MMSI | Merit Medical Systems | $99.00 | $108.83 | 9.93% | Buy |
| HOLX | Hologic | $72.26 | $74.20 | 2.68% | Buy |
| RMD | ResMed | $242.62 | $233.50 | -3.76% | Hold |